A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors

Clinical trial NCT07159828 · TERMINATED

Trial details

NCT number: NCT07159828
Sponsor: Axion Bio, Inc
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2025-09-15
Primary completion: 2026-04-16
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.